Cspc Pharmaceutgr Adr4 Stock Cash Per Share
| CVGU Stock | EUR 2.24 0.02 0.90% |
CSPC PHARMACEUTGR ADR4 fundamentals help investors to digest information that contributes to CSPC PHARMACEUTGR's financial success or failures. It also enables traders to predict the movement of CSPC Stock. The fundamental analysis module provides a way to measure CSPC PHARMACEUTGR's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CSPC PHARMACEUTGR stock.
CSPC |
CSPC PHARMACEUTGR ADR4 Company Cash Per Share Analysis
CSPC PHARMACEUTGR's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current CSPC PHARMACEUTGR Cash Per Share | 3.10 X |
Most of CSPC PHARMACEUTGR's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CSPC PHARMACEUTGR ADR4 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, CSPC PHARMACEUTGR ADR4 has a Cash Per Share of 3.1 times. This is 28.74% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The cash per share for all Germany stocks is 38.12% higher than that of the company.
CSPC Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CSPC PHARMACEUTGR's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CSPC PHARMACEUTGR could also be used in its relative valuation, which is a method of valuing CSPC PHARMACEUTGR by comparing valuation metrics of similar companies.CSPC PHARMACEUTGR is rated below average in cash per share category among its peers.
CSPC Fundamentals
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.22 % | |||
| Shares Outstanding | 2.98 B | |||
| Price To Earning | 18.49 X | |||
| Revenue | 30.72 B | |||
| Gross Profit | 21.14 B | |||
| EBITDA | 7.56 B | |||
| Net Income | 5.47 B | |||
| Cash And Equivalents | 9.28 B | |||
| Cash Per Share | 3.10 X | |||
| Total Debt | 316.71 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 9.41 X | |||
| Earnings Per Share | 0.25 X | |||
| Number Of Employees | 24.75 K | |||
| Beta | 0.75 | |||
| Market Capitalization | 12.8 B | |||
| Z Score | 24.0 | |||
| Annual Yield | 0.03 % | |||
| Last Dividend Paid | 0.24 |
About CSPC PHARMACEUTGR Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CSPC PHARMACEUTGR ADR4's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CSPC PHARMACEUTGR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CSPC PHARMACEUTGR ADR4 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in CSPC Stock
CSPC PHARMACEUTGR financial ratios help investors to determine whether CSPC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSPC with respect to the benefits of owning CSPC PHARMACEUTGR security.